Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Linares-Alarcón A"'
Autor:
Collado-Borell, R., Gomis-Pastor, M., Rodríguez-Cabezas, MA., Parro-Martín, A., Linares-Alarcón, A., Gutiérrez, E., Colominas-González, E., Fernández-Polo, A., Domínguez-Cantero, M., Arrondo-Velasco, A., Morillo-Verdugo, R.
Publikováno v:
In Health Policy and Technology September 2024 13(4)
Autor:
Ramón, Morillo-Verdugo, Roberto, Collado-Borell, Amaya, Arrondo-Velasco, Marcelo, Domínguez-Cantero, Aurora, Fernández-Polo, Elena, González-Corominas, Esperanza, Gutiérrez, Aránzazu, Linares-Alarcón, María de Los Ángeles, Parro-Martín, Miguel Ángel, Rodríguez-Cabezas, Mar, Gomis-Pastor
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 46(7)
To provide a practical guide for the implementation and use of Pharmaceutical Care through Telepharmacy by healthcare professionals and patients in its different scopes of application. To establish a definition of Telepharmacy and describe the techno
Autor:
Ramón Morillo-Verdugo, Tamara Aguilar Pérez, Mercedes Gimeno-Gracia, Carmen Rodríguez-González, María de las Aguas Robustillo-Cortes, Aitziber Illaro Uranga, Alicia Lázaro López, Angels Andreu Crespo, Aránzazu Linares Alarcón, Beatriz Proy Vega, Belén López García, Carlos Seguí Solanes, Carolina Aguilar Guisado, Elena Cárdaba García, Emilio Molina Cuadrado, Emilio Monte Boquet, Encarna Abad Lecha, Esther Vicente Escrig, Gabriel Mercadal Orfila, Herminia Navarro Aznárez, Inmaculada Nacle López, Irene Cañamares Orbis, Jara Gallardo Anciano, Javier Casas Arrate, Javier Sánchez-Rubio Ferrández, Joaquín Ignacio Serrano López, José Alberto Peña Pedrosa, Jose Sebastián Roldan González, Luis Carlos Fernández Lisón, Luis Margusino Framinan, Luis Ortega Valín, Maite Martin, Manuel Vélez, María Ángeles Andreu Crespo, Maria Carmen Rosado Maria, María García Coronel, Maria Jose Huertas Fernández, Mercedes Manzano García, Noelia Garrido Peña, Oihana Mora Atorrasagasti, Patricia Sanmartin Fenollera, Pilar Díaz Ruíz, Ramón San Miguel Elcano, Raquel Fresquet Molina, Vera Áreas del Águila, Dr Elena Rebollo-Gómez, Dr Vanessa Marfil
Publikováno v:
The Annals of pharmacotherapy. 57(2)
Background People living with human immunodeficiency virus (HIV) require specific pharmaceutical care (PC). Although the 2017 Capacity-Motivation-Opportunity (CMO) PC model allows a multidisciplinary approach that focuses on patient needs, it is too
Publikováno v:
Section 2: Selection, procurement and distribution.
Background and importance Recently, the EMA and AEMPS have approved the use of doravirine (DOR) a non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of adults infected with HIV-1 without past or present evidence of resistance to
Autor:
Linares Alarcón, Jaime
Publikováno v:
Repositorio Institucional-UCV
Universidad César Vallejo
UCV-Institucional
Universidad Cesar Vallejo
instacron:UCV
Universidad César Vallejo
UCV-Institucional
Universidad Cesar Vallejo
instacron:UCV
El trabajo de investigación tuvo como propósito de proponer un Programa de Habilidades Blandas para la Calidad en la Inversión Pública de la Municipalidad Provincial de Cutervo, utilizando el paradigma mixto de carácter descriptivo propositivo.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::f21b66ebb58f67fe8ce51953645d482c
Autor:
Morillo-Verdugo, Ramón, Collado-Borell, Roberto, Arrondo-Velasco, Amaya, Domínguez-Cantero, Marcelo, Fernández-Polo, Aurora, González-Corominas, Elena, Gutiérrez, Esperanza, Linares-Alarcón, Aránzazu, de los Ángeles Parro-Martín, María, Rodríguez-Cabezas, Miguel Ángel, Gomis-Pastor, Mar
Publikováno v:
Farmacia Hospitalaria (1130-6343); 2022 Supplement, Vol. 46, p115-122, 26p
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Fingolimod is an approved drug for relapsing–remitting multiple sclerosis (RRMS). Oral treatments allow better quality of life than injectable drugs but are not harmless. Aim and objectives To assess fingolimod safety in p
Autor:
Morillo-Verdugo, Ramón, Collado-Borell, Roberto, Arrondo-Velasco, Amaya, Domínguez-Cantero, Marcelo, Fernández-Polo, Aurora, González-Corominas, Elena, Gutiérrez, Esperanza, Linares-Alarcón, Aránzazu, de los Ángeles Parro-Martín, María, Rodríguez-Cabezas, Miguel Ángel, Gomis-Pastor, Mar
Publikováno v:
Farmacia Hospitalaria; October 2022, Vol. 46 Issue: 1, Number 1 Supplement 1 p115-122, 8p
Publikováno v:
Eur J Hosp Pharm
BACKGROUND: Alemtuzumab is a humanised monoclonal antibody that selectively targets CD52, resulting in depletion and subsequent distinct repopulation of circulating T and B lymphocytes. PURPOSE: To evaluate the effectiveness and security of alemtuzum
Publikováno v:
Drug information and pharmacotherapy.
Background Biologics are usually prescribed off-label in severe immune mediated inflammatory diseases. Unfortunately, off-label prescription is sometimes hampered in these diseases due to a lack of evidence of effectiveness. Purpose To assess the ris